ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 239,99
0,17%
Dow Jones
39 908,00
0,88%
DAX
18 869,36
0,78%
Brent Oil
82,725
0,21%
Bitcoin
65 829,14
6,96%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Organovo Holdings Inc (ONVO)

  7. Organovo Holdings Inc (ONVO) Actualités

ONVO

Organovo (ONVO)

Organovo Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ONVO
DateHeureSourceTitreSymboleSociété
14/05/202418h45Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:ONVOOrganovo Holdings Inc
14/05/202417h00GlobeNewswire Inc.Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)NASDAQ:ONVOOrganovo Holdings Inc
13/05/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONVOOrganovo Holdings Inc
09/05/202402h00GlobeNewswire Inc.Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public OfferingNASDAQ:ONVOOrganovo Holdings Inc
15/04/202414h05GlobeNewswire Inc.Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to PlaceboNASDAQ:ONVOOrganovo Holdings Inc
09/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ONVOOrganovo Holdings Inc
08/02/202422h56Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ONVOOrganovo Holdings Inc
08/02/202422h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONVOOrganovo Holdings Inc
26/01/202423h09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ONVOOrganovo Holdings Inc
25/01/202414h05GlobeNewswire Inc.Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis CongressNASDAQ:ONVOOrganovo Holdings Inc
09/01/202414h05GlobeNewswire Inc.Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis CongressNASDAQ:ONVOOrganovo Holdings Inc
06/12/202314h05GlobeNewswire Inc.Organovo Provides Timing for Release of FXR314 Phase 2 NASH ResultsNASDAQ:ONVOOrganovo Holdings Inc
01/12/202322h07Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ONVOOrganovo Holdings Inc
18/11/202300h41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONVOOrganovo Holdings Inc
15/11/202322h41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ONVOOrganovo Holdings Inc
13/11/202314h05GlobeNewswire Inc.CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and PlanNASDAQ:ONVOOrganovo Holdings Inc
08/11/202314h05GlobeNewswire Inc.Organovo Highlights FXR314 Combination Therapy Potential and PlanNASDAQ:ONVOOrganovo Holdings Inc
22/09/202322h05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ONVOOrganovo Holdings Inc
13/09/202323h07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ONVOOrganovo Holdings Inc
13/09/202323h06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ONVOOrganovo Holdings Inc
13/09/202323h06Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONVOOrganovo Holdings Inc
08/09/202318h46GlobeNewswire Inc.Organovo to Participate in the H.C. Wainwright Global Investment ConferenceNASDAQ:ONVOOrganovo Holdings Inc
23/08/202314h05GlobeNewswire Inc.Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 DataNASDAQ:ONVOOrganovo Holdings Inc
31/07/202322h05Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:ONVOOrganovo Holdings Inc
14/07/202323h05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ONVOOrganovo Holdings Inc
29/06/202322h07Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:ONVOOrganovo Holdings Inc
29/06/202322h06Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:ONVOOrganovo Holdings Inc
21/03/202313h05GlobeNewswire Inc.Organovo Announces FXR ProgramNASDAQ:ONVOOrganovo Holdings Inc
15/03/202322h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONVOOrganovo Holdings Inc
09/02/202322h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ONVOOrganovo Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:ONVO

Dernières Valeurs Consultées

LSE
94HL
Als 3 3.215% S
LSE
102T
KUCN
RACAUSDT
Radio Caca V2
COIN
SAKECEUR
BIT
P13DF9
BNP Paribas Issuance
BOV
NGRD3
Neogrid Participacoes ON
EU
BEB157554408
Euronext VPU Public auct...
TSX
RWE
CI MSCI Europe Low Risk ...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés